Chantal Depondt

Chantal Depondt

Auto-generated profile, based on publicly available information

Chantal Depondt

Laboratory of Experimental Neurology Université Libre De Bruxelles Brussels Belgium

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Science
Verified
Journal Article
Closed access
PDF file
KGKatrina Grasby
Katrina Grasby
NJNeda Jahanshad
Neda Jahanshad
JPJodie Painter
Jodie Painter
LCLucía Colodro Conde
Lucía Colodro Conde
JBJanita Bralten
Janita Bralten
EGEnhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group
Enhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group
INTRODUCTION: The cerebral cortex underlies our complex cognitive capabilities. Variations in human cortical surface area and thickness are associated with neurological, psychological, and behavioral traits and can be measured in vivo by magnetic resonance imaging (MRI). Studies in model organisms have identified genes that influence cortical structure, but little is known about common genetic variants that affect human cortical structure. RATIONALE: To identify genetic variants associated with human cortical structure at both global and regional levels, we conducted a genome-wide association meta-analysis of brain MRI data from 51,665 individuals across 60 cohorts. We analyzed the surface area and average thickness of the whole cortex and 34 cortical regions with known functional specializations. RESULTS: We identified 369 nominally genome-wide significant loci ( P < 5 × 10 −8 ) associated with cortical structure in a discovery sample of 33,992 participants of European ancestry. Of the 360 loci for which replication data were available, 241 loci influencing surface area and 66 influencing thickness remained significant after replication, with 237 loci passing multiple testing correction ( P < 8.3 × 10 −10 ; 187 influencing surface area and 50 influencing thickness). Common genetic variants explained 34% (SE = 3%) of the variation in total surface area and 26% (SE = 2%) in average thickness; surface area and thickness showed a negative genetic correlation ( r G = −0.32, SE = 0.05, P = 6.5 × 10 −12 ), which suggests that genetic influences have opposing effects on surface area and thickness. Bioinformatic analyses showed that total surface area is influenced by genetic variants that alter gene regulatory activity in neural progenitor cells during fetal development. By contrast, average thickness is influenced by active regulatory elements in adult brain samples, which may reflect processes that occur after mid-fetal development, such as myelination, branching, or pruning. When considered together, these results support the radial unit hypothesis that different developmental mechanisms promote surface area expansion and increases in thickness. To identify specific genetic influences on individual cortical regions, we controlled for global measures (total surface area or average thickness) in the regional analyses. After multiple testing correction, we identified 175 loci that influence regional surface area and 46 that influence regional thickness. Loci that affect regional surface area cluster near genes involved in the Wnt signaling pathway, which is known to influence areal identity. We observed significant positive genetic correlations and evidence of bidirectional causation of total surface area with both general cognitive functioning and educational attainment. We found additional positive genetic correlations between total surface area and Parkinson’s disease but did not find evidence of causation. Negative genetic correlations were evident between total surface area and insomnia, attention deficit hyperactivity disorder, depressive symptoms, major depressive disorder, and neuroticism. CONCLUSION: This large-scale collaborative work enhances our understanding of the genetic architecture of the human cerebral cortex and its regional patterning. The highly polygenic architecture of the cortex suggests that distinct genes are involved in the development of specific cortical areas. Moreover, we find evidence that brain structure is a key phenotype along the causal pathway that leads from genetic variation to differences in general cognitive function. Identifying genetic influences on human cortical structure.: ( A ) Measurement of cortical surface area and thickness from MRI. ( B ) Genomic locations of common genetic variants that influence global and regional cortical structure. ( C ) Our results support the radial unit hypothesis that the expansion of cortical surface area is driven by proliferating neural progenitor cells. ( D ) Cortical surface area shows genetic correlation with psychiatric and cognitive traits. Error bars indicate SE. IMAGE CREDITS: (A) K. COURTNEY; (C) M. R. GLASS

20 November 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SLSara Larivière
Sara Larivière
RRRaúl Rodríguez-Cruces
Raúl Rodríguez-Cruces
JRJessica Royer
Jessica Royer
MCMaria Eugenia Caligiuri
Maria Eugenia Caligiuri
AGAntonio Gambardella
Antonio Gambardella
BBBoris C. Bernhardt
Boris C. Bernhardt
Brain atrophy in human epilepsy syndromes is explainable by network architecture and strongest in hub regions.

7 September 2021 in Epilepsia
Verified
Journal Article
Open access
PDF file
LSLauren Swinnen
Lauren Swinnen
Christos ChatzichristosChristos Chatzichristos
Christos Chatzichristos
KJKatrien Jansen
Katrien Jansen
LLLieven Lagae
Lieven Lagae
CDChantal Depondt
Chantal Depondt
WPWim Van Paesschen
Wim Van Paesschen
Summary: Objective: Patients with absence epilepsy sensitivity <10% of their absences. The clinical gold standard to assess absence epilepsy is a 24‐h electroencephalographic (EEG) recording, which is expensive, obtrusive, and time‐consuming to review. We aimed to (1) investigate the performance of an unobtrusive, two‐channel behind‐the‐ear EEG‐based wearable, the Sensor Dot (SD), to detect typical absences in adults and children; and (2) develop a sensitive patient‐specific absence seizure detection algorithm to reduce the review time of the recordings.Methods: We recruited 12 patients (median age = 21 years, range = 8–50; seven female) who were admitted to the epilepsy monitoring units of University Hospitals Leuven for a 24‐h 25‐channel video‐EEG recording to assess their refractory typical absences. Four additional behind‐the‐ear electrodes were attached for concomitant recording with the SD. Typical absences were defined as 3‐Hz spike‐and‐wave discharges on EEG, lasting 3 s or longer. Seizures on SD were blindly annotated on the full recording and on the algorithm‐labeled file and consequently compared to 25‐channel EEG annotations. Patients or caregivers were asked to keep a seizure diary. Performance of the SD and seizure diary were measured using the F1 score.Results: We concomitantly recorded 284 absences on video‐EEG and SD. Our absence detection algorithm had a sensitivity of .983 and false positives per hour rate of .9138. Blind reading of full SD data resulted in sensitivity of .81, precision of .89, and F1 score of .73, whereas review of the algorithm‐labeled files resulted in scores of .83, .89, and .87, respectively. Patient self‐reporting gave sensitivity of .08, precision of 1.00, and F1 score of .15.Significance: Using the wearable SD, epileptologists were able to reliably detect typical absence seizures. Our automated absence detection algorithm reduced the review time of a 24‐h recording from 1‐2 h to around 5–10 min.

1 February 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JTJennifer Thorpe
Jennifer Thorpe
SASamantha Ashby
Samantha Ashby
AHAsma Hallab
Asma Hallab
DDDing Ding
Ding Ding
MAMaria Andraus
Maria Andraus
Arjune SenArjune Sen
Arjune Sen

26 June 2019 in Epilepsia Open
Verified
Journal Article
Open access
PDF file
KSKatri Silvennoinen
Katri Silvennoinen
NLNikola de Lange
Nikola de Lange
SZSara Zagaglia
Sara Zagaglia
SBSimona Balestrini
Simona Balestrini
GAGanna Androsova
Ganna Androsova
TCthe EpiPGX Consortium
the EpiPGX Consortium
Objective: To study the effectiveness and tolerability of antiepileptic drugs (AEDs) commonly used in juvenile myoclonic epilepsy (JME).Methods: People with JME were identified from a large database of individuals with epilepsy, which includes detailed retrospective information on AED use. We assessed secular changes in AED use and calculated rates of response (12‐month seizure freedom) and adverse drug reactions (ADRs) for the five most common AEDs. Retention was modeled with a Cox proportional hazards model. We compared valproate use between males and females.Results: We included 305 people with 688 AED trials of valproate, lamotrigine, levetiracetam, carbamazepine, and topiramate. Valproate and carbamazepine were most often prescribed as the first AED. The response rate to valproate was highest among the five AEDs (42.7%), and significantly higher than response rates for lamotrigine, carbamazepine, and topiramate; the difference to the response rate to levetiracetam (37.1%) was not significant. The rates of ADRs were highest for topiramate (45.5%) and valproate (37.5%). Commonest ADRs included weight change, lethargy, and tremor. In the Cox proportional hazards model, later start year (1.10 [1.08‐1.13],P < 0.001) and female sex (1.41 [1.07‐1.85],P = 0.02) were associated with shorter trial duration. Valproate was associated with the longest treatment duration; trials with carbamazepine and topiramate were significantly shorter (HR [CI]: 3.29 [2.15‐5.02],P < 0.001 and 1.93 [1.31‐2.86],P < 0.001). The relative frequency of valproate trials shows a decreasing trend since 2003 while there is an increasing trend for levetiracetam. Fewer females than males received valproate (76.2% vs 92.6%,P = 0.001).Significance: In people with JME, valproate is an effective AED; levetiracetam emerged as an alternative. Valproate is now contraindicated in women of childbearing potential without special precautions. With appropriate selection and safeguards in place, valproate should remain available as a therapy, including as an alternative for women of childbearing potential whose seizures are resistant to other treatments.

22 February 2011 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
CDC. Depondt
C. Depondt
PGP. Godard
P. Godard
RER. S. Espel
R. S. Espel
ACA. L. Da Cruz
A. L. Da Cruz
PLP. Lienard
P. Lienard
MPM. Pandolfo
M. Pandolfo